The price of Omeros Corporation (NASDAQ: OMER) closed at $4.44 in the last session, down -7.11% from day before closing price of $4.78. In other words, the price has decreased by -$0.3400 from its previous closing price. On the day, 596396 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
We take a closer look at OMER’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.90 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.33. For the most recent quarter (mrq), Quick Ratio is recorded 2.39 and its Current Ratio is at 2.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on December 08, 2022, Downgraded its rating to Neutral and sets its target price to $2 from $12 previously.
On November 08, 2022, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $8 to $3.
BofA Securities Downgraded its Buy to Neutral on June 08, 2022, whereas the target price for the stock was revised from $12 to $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 17 when Demopulos Gregory A MD bought 15,000 shares for $1.68 per share. The transaction valued at 25,200 led to the insider holds 123,945 shares of the business.
Demopulos Peter A MD bought 10,000 shares of OMER for $15,300 on Nov 15. The Director now owns 208,516 shares after completing the transaction at $1.53 per share. On May 22, another insider, Cable Thomas J., who serves as the Director of the company, sold 5,000 shares for $6.53 each. As a result, the insider received 32,650 and left with 35,067 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OMER now has a Market Capitalization of 300.18M and an Enterprise Value of 330.75M. As of this moment, Omeros’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.85.
Stock Price History:
Over the past 52 weeks, OMER has reached a high of $7.80, while it has fallen to a 52-week low of $0.92. The 50-Day Moving Average of the stock is 3.7010, while the 200-Day Moving Average is calculated to be 3.7128.
Shares Statistics:
According to the various share statistics, OMER traded on average about 720.09K shares per day over the past 3-months and 531.74k shares per day over the past 10 days. A total of 62.83M shares are outstanding, with a floating share count of 60.32M. Insiders hold about 4.05% of the company’s shares, while institutions hold 39.92% stake in the company. Shares short for OMER as of Feb 15, 2024 were 13.83M with a Short Ratio of 19.21, compared to 13.82M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 22.00% and a Short% of Float of 22.92%.
Earnings Estimates
The company has 2 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.55 for the current quarter, with a high estimate of -$0.46 and a low estimate of -$0.65, while EPS last year was $2.05. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$2.17 and -$2.38 for the fiscal current year, implying an average EPS of -$2.27. EPS for the following year is -$1.78, with 2 analysts recommending between -$1.06 and -$2.51.
